InvestorsHub Logo
Followers 4
Posts 276
Boards Moderated 0
Alias Born 02/12/2019

Re: eom7 post# 602

Wednesday, 05/06/2020 3:17:24 PM

Wednesday, May 06, 2020 3:17:24 PM

Post# of 2792
Pritumumab

Well, looks like some new buyers have joined in my friend!

We expect that data from the cell line testing will come in sometime soon.

"The Company has initiated tests to assess the possibility that its lead asset, the monoclonal antibody Pritumumab (PTB) could be used as a potential therapy against the novel coronavirus, or SARS-CoV-2"

https://www.globenewswire.com/news-release/2020/04/22/2019823/0/en/Nascent-Biotech-Provides-Shareholder-Update-on-COVID-19-Therapy-and-Brain-Cancer-Trials.html

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NBIO News